620 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 13 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CD52CD52 moleculeCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Expressed in all
CD80CD80 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD86CD86 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
CHD1Chromodomain helicase DNA binding protein 1Enzymes
FDA approved drug targets
Expressed in all
CHRFAM7ACHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusionFDA approved drug targets
Predicted membrane proteins
Mixed
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRM2Cholinergic receptor, muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM4Cholinergic receptor, muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM5Cholinergic receptor, muscarinic 5FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRNA10Cholinergic receptor, nicotinic, alpha 10 (neuronal)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
CHRNA2Cholinergic receptor, nicotinic, alpha 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
CHRNA3Cholinergic receptor, nicotinic, alpha 3 (neuronal)FDA approved drug targets
Predicted membrane proteins
Tissue enriched
CHRNA4Cholinergic receptor, nicotinic, alpha 4 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CHRNB2Cholinergic receptor, nicotinic, beta 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CHRNB4Cholinergic receptor, nicotinic, beta 4 (neuronal)FDA approved drug targets
Predicted membrane proteins
Group enriched
CKBCreatine kinase, brainCancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
CKMCreatine kinase, muscleCandidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
CKMT1ACreatine kinase, mitochondrial 1AEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Mixed
CKMT1BCreatine kinase, mitochondrial 1BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Mixed
CKMT2Creatine kinase, mitochondrial 2 (sarcomeric)Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Group enriched
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
CNR2Cannabinoid receptor 2 (macrophage)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
COMTCatechol-O-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Expressed in all
CPS1Carbamoyl-phosphate synthase 1, mitochondrialDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Group enriched
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all
CPT2Carnitine palmitoyltransferase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
CRBNCereblonDisease related genes
FDA approved drug targets
Expressed in all
CSF2RAColony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CSF2RBColony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
CSF3RColony stimulating factor 3 receptor (granulocyte)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CTLA4Cytotoxic T-lymphocyte-associated protein 4CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CXCR4Chemokine (C-X-C motif) receptor 4Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CYP11B1Cytochrome P450, family 11, subfamily B, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Tissue enriched
CYP17A1Cytochrome P450, family 17, subfamily A, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
CYP19A1Cytochrome P450, family 19, subfamily A, polypeptide 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
CYP51A1Cytochrome P450, family 51, subfamily A, polypeptide 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
CYSLTR1Cysteinyl leukotriene receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
CYSLTR2Cysteinyl leukotriene receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
DBHDopamine beta-hydroxylase (dopamine beta-monooxygenase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
DCKDeoxycytidine kinaseEnzymes
FDA approved drug targets
Expressed in all
DDCDopa decarboxylase (aromatic L-amino acid decarboxylase)Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
DDR2Discoidin domain receptor tyrosine kinase 2CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
DHFRDihydrofolate reductaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Mixed
DHODHDihydroorotate dehydrogenase (quinone)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Expressed in all

« prev | Page of 13 | next »